223 related articles for article (PubMed ID: 21711257)
1. Botulinum toxin treatment of secondary headaches and cranial neuralgias: a review of evidence.
Linde M; Hagen K; Stovner LJ
Acta Neurol Scand Suppl; 2011; (191):50-5. PubMed ID: 21711257
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
Sycha T; Kranz G; Auff E; Schnider P
J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
[TBL] [Abstract][Full Text] [Related]
3. Nerve block for the treatment of headaches and cranial neuralgias - a practical approach.
Dach F; Éckeli ÁL; Ferreira Kdos S; Speciali JG
Headache; 2015 Feb; 55 Suppl 1():59-71. PubMed ID: 25644836
[TBL] [Abstract][Full Text] [Related]
4. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
Oh HM; Chung ME
Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
[TBL] [Abstract][Full Text] [Related]
5. Use of Botulinum Toxin in Orofacial Clinical Practice.
Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
[TBL] [Abstract][Full Text] [Related]
6. The Diagnosis and Management of Posttraumatic Headache with Associated Painful Cranial Neuralgias: a Review and Case Series.
Mathew PG; Cooper W
Curr Pain Headache Rep; 2021 Jun; 25(8):54. PubMed ID: 34160700
[TBL] [Abstract][Full Text] [Related]
7. Botulinum Toxin for the Treatment of Neuropathic Pain.
Park J; Park HJ
Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28837075
[TBL] [Abstract][Full Text] [Related]
8. Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.
Luvisetto S; Gazerani P; Cianchetti C; Pavone F
Toxins (Basel); 2015 Sep; 7(9):3818-44. PubMed ID: 26404377
[TBL] [Abstract][Full Text] [Related]
9. Clinical profile of headache and cranial neuralgias.
Shah PA; Nafee A
J Assoc Physicians India; 1999 Nov; 47(11):1072-5. PubMed ID: 10862316
[TBL] [Abstract][Full Text] [Related]
10. A Cross-Sectional Clinic-Based Study in Patients With Side-Locked Unilateral Headache and Facial Pain.
Prakash S; Rathore C; Makwana P; Dave A
Headache; 2016 Jul; 56(7):1183-93. PubMed ID: 27256162
[TBL] [Abstract][Full Text] [Related]
11. Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.
Sandrini G; De Icco R; Tassorelli C; Smania N; Tamburin S
J Headache Pain; 2017 Dec; 18(1):38. PubMed ID: 28324318
[TBL] [Abstract][Full Text] [Related]
12. Neuromodulators for Atypical Facial Pain and Neuralgias: A Systematic Review and Meta-Analysis.
Do TM; Unis GD; Kattar N; Ananth A; McCoul ED
Laryngoscope; 2021 Jun; 131(6):1235-1253. PubMed ID: 33037835
[TBL] [Abstract][Full Text] [Related]
13. [Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].
Halb L; Amann BJ; Bornemann-Cimenti H
Nervenarzt; 2017 Apr; 88(4):408-414. PubMed ID: 27924350
[TBL] [Abstract][Full Text] [Related]
14. The Neuralgias.
Wilhour D; Nahas SJ
Curr Neurol Neurosci Rep; 2018 Aug; 18(10):69. PubMed ID: 30116913
[TBL] [Abstract][Full Text] [Related]
15. Cranial Neuralgias.
Tepper SJ
Continuum (Minneap Minn); 2018 Aug; 24(4, Headache):1157-1178. PubMed ID: 30074554
[TBL] [Abstract][Full Text] [Related]
16. Cranial Neuralgias.
Bajwa ZH; Smith SS; Khawaja SN; Scrivani SJ
Oral Maxillofac Surg Clin North Am; 2016 Aug; 28(3):351-70. PubMed ID: 27475511
[TBL] [Abstract][Full Text] [Related]
17. Headaches of otolaryngological interest: current status while awaiting revision of classification. Practical considerations and expectations.
Farri A; Enrico A; Farri F
Acta Otorhinolaryngol Ital; 2012 Apr; 32(2):77-86. PubMed ID: 22767967
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity between hypothyroidism and headache disorders in a Mexican population.
Fernández-Garza LE; Marfil A
Rev Neurol; 2022 Jul; 75(1):13-16. PubMed ID: 35765824
[TBL] [Abstract][Full Text] [Related]
19. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Naumann M; So Y; Argoff CE; Childers MK; Dykstra DD; Gronseth GS; Jabbari B; Kaufmann HC; Schurch B; Silberstein SD; Simpson DM;
Neurology; 2008 May; 70(19):1707-14. PubMed ID: 18458231
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials.
Del Sorbo F; Albanese A
Toxicon; 2015 Dec; 107(Pt A):89-97. PubMed ID: 26365917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
